drugset / Trial / NCT06219018

Effect of Honey For CIN II

NCT06219018 ↗

Phase 1/2 Recruiting 60 enrolled Zuyderland Medical Center
NaSingle-groupOpen-labelTreatment

Summary

The following hypothesis is tested: Medical grade honey in CIN II causes a higher clearance of the hr-HPV virus and an increase in the normalization of CIN II lesions compared to expectant management.

Timeline

Start
2024-12-30
Primary completion
2026-12-01
Completion
2027-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject medical-grade honey Unknown 5 g Intravenous